Advances in the application of molecular docking in nanomedicine

X. Li, Zhen LiJournal of Computer-Aided Molecular Design 2026 · DOI

TL;DR

This review explores how molecular docking—a cornerstone of traditional drug discovery—is being repurposed to revolutionize nanomedicine. By acting as a "virtual sieve," docking allows researchers to predict how nanoparticles interact with drugs and biological systems, potentially replacing years of expensive "trial-and-error" lab work with precise, computer-guided design.

What Problem Does This Paper Address?

Nanomedicine involves designing incredibly complex systems: nanoparticles that must carry a drug, stay stable in the blood, hit a specific target (like a tumor), and avoid being toxic. Historically, creating these "smart" drugs has relied on intuition and iterative lab testing, which is slow and costly.

While molecular docking is great at predicting how a small drug molecule fits into a protein "pocket," nanomaterials are much larger, more flexible, and chemically diverse. This paper addresses the gap in how we apply these established computational tools to the unique, messy world of nanotechnology, summarizing current successes and the technical hurdles that still remain.

Methods

The authors review the fundamental mechanics of molecular docking and how they are adapted for nanomedicine. The process generally follows two interrelated steps:

  1. Conformational Searching: Algorithms (like Genetic Algorithms or Monte Carlo simulations) explore thousands of ways a "ligand" (the drug or nanoparticle) can orient itself relative to a "receptor" (a protein or cell membrane).
  2. Functional Scoring: Mathematical functions estimate the "binding energy" of these orientations to find the most stable and likely interaction.

The paper highlights the use of standard software—such as AutoDock Vina, SwissDock, and Glide—but notes that in nanomedicine, these are often used to model non-traditional interactions, such as a peptide wrapping around a carbon nanotube or a nanoparticle adsorbing onto a cell surface.

Datasets

As a review article, this paper does not introduce a new dataset. Instead, it discusses how researchers utilize existing structural databases (like the Protein Data Bank) and chemical libraries to perform "virtual screening." The authors point out a significant bottleneck: there is a lack of high-quality, high-resolution structural data specifically for nanomaterial-biomolecule complexes, which makes training more accurate "scoring functions" difficult.

Key Insights and Ideas

  • The "Virtual Sieve" Concept: Docking isn't meant to provide a final answer but to rapidly narrow down thousands of candidate materials to the top 1% most likely to work in the lab.
  • Predicting the "Protein Corona": When a nanoparticle enters the body, it is immediately coated in blood proteins (a "corona"). Docking can predict which proteins will stick, which is the primary factor in whether the body’s immune system will attack the nanoparticle or let it pass.
  • Mechanistic "Aha" Moments: Docking has revealed why certain materials work. For example, it showed that hydrogen bonding is the decisive force that allows the drug Remdesivir to be encapsulated in PLGA nanoparticles for COVID-11 therapy.
  • Toxicity Warning System: By simulating how nanoparticles bind to non-target proteins (like hemoglobin), docking can act as an early warning system for potential biosafety issues before animal testing even begins.

Key Results

The paper cites several successful applications:

  • Antibacterial Discovery: Researchers used docking to find that Fullerene C60 has a higher binding affinity for bacterial proteins than ZnO or CuO, explaining its superior antibacterial performance in experiments.
  • Stabilizer Screening: Docking was used to identify Poloxamer-407 as the optimal stabilizer for certain nanodrugs, providing a molecular-level explanation for why it prevents the drugs from clumping together.
  • Targeted Delivery: Simulations confirmed that magnetic nanoparticles modified with hyaluronic acid could readily bind to CD44 receptors on cancer cells, validating a strategy for targeted chemotherapy.

Limitations and Future Work

The authors are honest about the "growing pains" of this field:

  • Force Field Mismatch: Most docking tools were built for organic molecules. They often struggle with the unique physics of nanomaterials, such as $\pi-\pi$ stacking or charge transfer at inorganic surfaces.
  • The Flexibility Problem: Large nanoparticles have "extremely high conformational freedom." Current software struggles to simulate the way a long polymer chain on a nanoparticle surface might wiggle and change shape.
  • The Solvent Problem: Most models treat water as a simple background, but at the nanoscale, the specific "hydration layer" of water molecules around a particle can completely change how it binds.

The Future: The authors predict a shift toward "Integrated Computing"—combining molecular docking with Machine Learning and Multiscale Simulations to handle the sheer complexity of the nano-bio interface.

Summary updated

BibTeX
@article{li2026advances,
  author = {X. Li and Zhen Li},
  title = {{Advances in the application of molecular docking in nanomedicine}},
  journal = {Journal of Computer-Aided Molecular Design},
  year = {2026},
  doi = {10.1007/s10822-026-00779-5},
}
Figure